Human [Leu60] insulin-like Growth Factor-I ([Leu60] IGF-I) is an analogue of human IGF-I which has a Leucine substitution in place of Tyrosine at position 60 of the human IGF-I sequence. [Leu60]IGF-I has normal binding to acid-stripped human serum binding proteins but has reduced binding to the type 1 IGF receptor and to the insulin receptor compared to IGF-I. It is a useful analogue for studying the relative effects of IGF-I through the type 1 receptor and IGF binding proteins.
This product is manufactured in Australia by GroPep Bioreagents.
| Size | 100 µg |
| Source Species | Recombinant |
| Expression System | Ecoli |
| Storage | 2-8°C |
| Alternative Names | Human [Leu60] Insulin-like Growth |

![Human [Leu60] IGF-I](https://eaglebio.com/wp-content/uploads/2025/08/GroPep-logo-header-1.png)